PTC Therapeutics Inc (NASDAQ:PTCT)
| 57.01 Delayed Data As of Mar 03 |  -0.31 / -0.54%Today’s Change | 30.79 Today|||52-Week Range 70.82 | -6.59% Year-to-Date |
Latest PTCT News | Press Releases
| PTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates Feb 25 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Feb 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 57.32 |
| Today’s open | 57.42 |
| Day’s range | 56.38 - 58.00 |
| Volume | 24,875 |
| Average volume (3 months) | 502,866 |
| Market cap | $4.0B |
Data as of 3:59pm ET, 03/03/2021
Growth & Valuation
| Earnings growth (last year) | -55.27% |
| Earnings growth (this year) | +12.99% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +24.04% |
| P/E ratio | NM |
| Price/Sales | 10.58 |
| Price/Book | 8.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | -0.49 | -1.27% |
| ---- | ||
| GRFSGrifols SA | -0.16 | -0.96% |
| HCMHutchison China Medi... | +0.04 | +0.13% |
Data as of 4:00pm ET, 03/03/2021
Financials
| Next reporting date | May 6, 2021 |
| EPS forecast (this quarter) | -$1.59 |
| Annual revenue (last year) | $380.8M |
| Annual profit (last year) | -$438.2M |
| Net profit margin | -115.07% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South Plainfield, New Jersey |
Forecasts
